Traumatic Brain Injury: The Violent and Silent Epidemic

Friday, February 19, 2010: 1:30 PM-3:00 PM
Room 2 (San Diego Convention Center)
Every 15 seconds, a U.S. citizen sustains a significant traumatic brain injury (TBI). Every 5 minutes, someone is permanently disabled as a consequence of TBI. Between 1.5 million and 2 million U.S. civilians sustain a TBI each year. The Centers for Disease Control and Prevention estimates that 5.3 million civilians are living with some degree of disability from a traumatic brain injury. TBI has also been labeled the signature wound of the Iraq war, with up to 20 percent of combat personnel having suffered a TBI while in theater. The aggregate annual cost of TBI in the United States approached $60 billion in 2000. Despite the enormity of the problem, scientists have not identified an effective pharmacological agent that improves outcomes for TBI. Why have no agents been successfully developed, and what is being done about this devastating disease? New initiatives and research are finally bringing hope through a more fundamental understanding of the disease and the development of novel treatments. This symposium brings together three outstanding individuals to discuss 1) redefining TBI, the latest findings on the mechanisms, and new perspectives; 2) mild TBI, a silent epidemic -- new understanding of the injury and mechanisms involved; and 3) promising new treatments and current trials.
Mahlon DeLong, Emory University School of Medicine
David Wright, Emory University School of Medicine
David Wright, Emory University School of Medicine
Geoffrey Manley, University of California
Redefining Traumatic Brain Injury
Douglas Smith, University of Pennsylvania
Mild Traumatic Brain Injury
David Wright, Emory University School of Medicine
Current Clinical Trials in Traumatic Brain Injury
See more of: Cognitive Function and Development
See more of: Symposia